HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Dr. Lal Pathlabs’ arm acquires remaining 30% stake in Centrapath Labs
Oct-14-2026

Dr. Lal Pathlabs’ Wholly Owned Subsidiary-- PathLabs Unifiers (PUPL) has acquired the remaining 30% equity stake in Centrapath Labs (CPL), a Subsidiary of PUPL, on October 13, 2026. Pursuant to the aforesaid acquisition, CPL has become a Wholly Owned Subsidiary of PUPL.  

Dr. Lal Pathlabs is a provider of diagnostic and related healthcare tests and services in India. 


  RELATED NEWS >>